desintegron B

Known as: B-14, desintegron-B, surface-active agent B-14 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2016
02419752016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE Several mechanisms have been proposed to explain tamoxifen resistance of estrogen receptor (ER) -positive tumors, but a… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The 21-gene OncotypeDX recurrence score (RS) assay quantifies the risk of distant recurrence in tamoxifen-treated… (More)
Is this relevant?
2010
2010
OBJECTIVE Oncotype DX, a 21-gene assay, was clinically validated as a predictor of 10-year recurrence-free survival and treatment… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Locoregional failure (LRF) after breast-conserving therapy (BCT) is associated with increased risk of distant disease and… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Findings from the National Surgical Adjuvant Breast and Bowel Project B-14 and B-20 trials showed that tamoxifen… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Six chlorpyrifos-degrading bacteria were isolated from an Australian soil and compared by biochemical and molecular methods. The… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Obesity is associated with both increased breast cancer risk and poorer prognosis after disease onset. However, little… (More)
Is this relevant?
2003
2003
Cervical carcinoma is the leading cause of cancer death in Quechua indians from Jujuy (northwestern Argentina). To determine the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Previously reported information from B-14, a National Surgical Adjuvant Breast and Bowel Project (NSABP) randomized… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND In 1982, the National Surgical Adjuvant Breast and Bowel Project initiated a randomized, double-blinded, placebo… (More)
Is this relevant?